Literature DB >> 7856098

Overexpression of human immunodeficiency virus type 1 protease increases intracellular cleavage of Gag and reduces virus infectivity.

B G Luukkonen1, E M Fenyö, S Schwartz.   

Abstract

Here we have investigated if human immunodeficiency virus type 1 (HIV-1) protease expressed in trans can interfere with production of infectious HIV-1 particles. Protease produced from a Tat and Rev inducible expression plasmid specifically cleaved HIV-1 p55Gag in a dose-dependent manner. Coexpression of protease and an infectious HIV-1 proviral clone resulted in increased intracellular cleavage of p55Gag. As a consequence, virus production and virus infectivity was significantly reduced. These results suggest that overexpression of HIV-1 protease in HIV-1-infected cells is a powerful way to inhibit production of infectious virions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7856098     DOI: 10.1006/viro.1995.1008

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Reversible oxidative modification as a mechanism for regulating retroviral protease dimerization and activation.

Authors:  David A Davis; Cara A Brown; Fonda M Newcomb; Emily S Boja; Henry M Fales; Joshua Kaufman; Stephen J Stahl; Paul Wingfield; Robert Yarchoan
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Human immunodeficiency virus type 1 (HIV-1) protein Vif inhibits the activity of HIV-1 protease in bacteria and in vitro.

Authors:  M Kotler; M Simm; Y S Zhao; P Sova; W Chao; S F Ohnona; R Roller; C Krachmarov; M J Potash; D J Volsky
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Recognition of prominent viral epitopes induced by immunization with human immunodeficiency virus type 1 regulatory genes.

Authors:  J Hinkula; C Svanholm; S Schwartz; P Lundholm; M Brytting; G Engström; R Benthin; H Glaser; G Sutter; B Kohleisen; V Erfle; K Okuda; H Wigzell; B Wahren
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Redundant roles for nucleocapsid and matrix RNA-binding sequences in human immunodeficiency virus type 1 assembly.

Authors:  David E Ott; Lori V Coren; Tracy D Gagliardi
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant.

Authors:  David E Ott; Lori V Coren; Elena N Chertova; Tracy D Gagliardi; Kunio Nagashima; Raymond C Sowder; Dexter T K Poon; Robert J Gorelick
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  The SIVmac239 Pr55Gag isoform, SIV p43, suppresses proteolytic cleavage of Pr55Gag.

Authors:  Michael G Nicholson; Sheila A Barber; Janice E Clements
Journal:  Virology       Date:  2006-11-07       Impact factor: 3.616

7.  p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.

Authors:  M Huang; J M Orenstein; M A Martin; E O Freed
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  The nucleocapsid region of human immunodeficiency virus type 1 Gag assists in the coordination of assembly and Gag processing: role for RNA-Gag binding in the early stages of assembly.

Authors:  David E Ott; Lori V Coren; Teresa Shatzer
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

9.  Design of a trans protease lentiviral packaging system that produces high titer virus.

Authors:  Karen A Westerman; Zhujun Ao; Eric A Cohen; Philippe Leboulch
Journal:  Retrovirology       Date:  2007-12-28       Impact factor: 4.602

10.  HIV-1 Nef inhibits Protease activity and its absence alters protein content of mature viral particles.

Authors:  Luiza M Mendonça; Sandro C Poeys; Celina M Abreu; Amilcar Tanuri; Luciana J Costa
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.